NUTRIM School of Nutrition and Translational Research in Metabolism aims to contribute to excellence in health maintenance and personalized medicine by unraveling lifestyle and disease induced derangements in metabolism and by developing targeted nutritional, exercise and drug interventions. This is facilitated by a state of the art research infrastructure and close interaction between scientists, clinicians, master and PhD students.
NUTRIM is proud to announce its 25th anniversary. It is time to celebrate our achievements together with our network! The celebration activities spread over November and include the two-day Introduction Course for new PhD Students (1 - 2 November) with NUTRIM Café (2 November), Pizza Movie Night (9 November), Battle of the Departments Quiz (16 November)...
... and the Annual NUTRIM Symposium with the theme Nutrition and Metabolism: Translation in Action followed by dinner buffet and party (22 November).
NUTRIM research focuses on chronic diseases, including diabetes, COPD, inflammatory bowel disease, liver disease and renal disease, and contributes to improving cancer care. Biomedical research is directly linked to clinical trials and research focusing on behavioural interventions and health promotion. A primary goal is to accelerate the translation of science to patient and population. This distinct profile has placed NUTRIM at the cutting-edge of various related domains. NUTRIM's research lines are:
Division I: Obesity, Diabetes & Cardiovascular Health
Division II: Liver & Digestive Health
Division III: Respiratory & Age-related Health
NUTRIM offers a PhD training programme for students who aspire a broad understanding of human nutrition, metabolism and toxicology, next to outstanding research capabilities. NUTRIM researchers also teach in several master’s programmes, such as ‘Biomedical Sciences’, ‘Physician Clinical Scientist’ and ‘Health Food Innovation Management’.
"NUTRIM has an internationally leading position in nutritional and metabolic management of Chronic obstructive Pulmonary Disease."
“Diabetes research in the Netherlands is, in comparison to other countries in the world, very competitive.”
“My aim is to understand the mechanisms by which liver inflammation develops and to develop new non-invasive markers to detect inflammation. And, of course, to develop novel treatment options for this disease.”
“NUTRIM’s strength lies in the fact that the patients’ interests are not overlooked and a lot of attention is paid to ‘translational research’.”
NUTRIM – one of the six research schools within Maastricht UMC+ is celebrating its 25th anniversary.
Report about the Dutch Agri Food Week dinner on the Brightlands Campus Greenport Venlo.
Five of the 154 granted Veni-applications came from Maastricht.